The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Quantifying the evolution of tumor architecture using serial circulating tumor DNA.
 
Jason Henry
No Relationships to Disclose
 
Jonathan M. Loree
Consulting or Advisory Role - Ipsen; Novartis; Taiho Pharmaceutical
 
John H. Strickler
Consulting or Advisory Role - Amgen; Bayer; Celgene; Chugai/Roche; Genentech/Roche
Research Funding - Abbvie (Inst); Cascadian Therapeutics (Inst); Exelixis (Inst); Gilead Sciences (Inst); Leap Therapeutics; Macrogenics; MedImmune (Inst); OncoMed (Inst); Regeneron (Inst); Roche/Genentech (Inst); Sanofi (Inst); Seagen
 
Kanwal Pratap Singh Raghav
Consulting or Advisory Role - Bayer (Inst); Genentech (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Van K. Morris
Consulting or Advisory Role - Clinical Genomics
Travel, Accommodations, Expenses - Array BioPharma
 
Victoria M. Raymond
Employment - Guardant Health; Trovagene
Stock and Other Ownership Interests - Guardant Health; Trovagene
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Biolase; Guardant Health
Stock and Other Ownership Interests - Biolase; Guardant Health
Research Funding - Guardant Health
 
Rona Yaeger
Research Funding - Array BioPharma; GlaxoSmithKline; Novartis
Travel, Accommodations, Expenses - Array BioPharma
 
Ryan Bruce Corcoran
Consulting or Advisory Role - Amgen; Astex Pharmaceuticals; Avidity Nanomedicines; Bristol-Myers Squibb; FOGPharma; Genentech; Loxo; Merrimack; N-of-One; Roche; Roivant; Shire; Spectrum Pharmaceuticals; Symphogen; Taiho Pharmaceutical; Warp Drive Bio
Research Funding - AstraZeneca; Sanofi
 
Michael J. Overman
Consulting or Advisory Role - Bristol-Myers Squibb; Gritstone Bio; MedImmune; Roche/Genentech
Research Funding - Bristol-Myers Squibb; MedImmune; Merck; Roche
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch; Navire
Consulting or Advisory Role - Amal Therapeutics; Biocartis; EMD Serono; Genentech; Holy Stone Healthcare; Holy Stone Healthcare; Karyopharm Therapeutics; Merck; Navire; Roche; Symphogen
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)